Scarica l'app Stockscreener
83.19
5.04%
3.99
Dopo l'orario di chiusura:
83.20
0.01
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$79.20
Aprire:
$80
Volume 24 ore:
9.67M
Relative Volume:
0.97
Capitalizzazione di mercato:
$106.49B
Reddito:
$36.36B
Utile/perdita netta:
$4.84B
Rapporto P/E:
22.36
EPS:
3.7212
Flusso di cassa netto:
$5.43B
1 W Prestazione:
+3.32%
1M Prestazione:
+12.80%
6M Prestazione:
-13.39%
1 anno Prestazione:
-5.77%
Intervallo 1D:
$79.90
$83.31
Intervallo di 1 settimana:
$78.14
$83.31
Portata 52W:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
83.19 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
ABT
Abbott Laboratories
|
95.40 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
326.54 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.14 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
94.37 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Ripresa | Barclays | Overweight |
| 2026-02-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-03 | Ripresa | Citigroup | Buy |
| 2026-01-30 | Ripresa | Wells Fargo | Overweight |
| 2026-01-06 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Medtronic plc (MDT) & Retia Expand Partnership to Target High-Risk Surgical and Critically ill Patients - Yahoo Finance
Price to sales forward of Medtronic Plc – MIL:1MDT - TradingView
Medtronic plc highlights its global medical technology role as investors track long-term growth driv - AD HOC NEWS
Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock? - The Motley Fool
Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus
Medtronic PLC Stock (MDT) Closed Down by 3.30% on Jun 30: Key Drivers Unveiled - TradingKey
Medtronic reports solid Q4 earnings, shares steady ahead August update - AD HOC NEWS
Is Medtronic plc (MDT) A Good Stock To Buy Now? - Insider Monkey
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
Medtronic plc refines diabetes portfolio, shares reflect mixed analyst stance - AD HOC NEWS
MiniMed widens board as it builds out as an independent diabetes tech company - Stock Titan
Medtronic clears spin-off milestone, diabetes IPO plans keep the stock in focus - AD HOC NEWS
Here is Why Medtronic (MDT) is One of the Best Long Term Stocks to Buy According to Hedge Funds - Yahoo Finance
Medtronic: Coming Back, But Not Yet Ready For Greatness (NYSE:MDT) - Seeking Alpha
Is Medtronic (MDT) A Bargain After Renal Denervation Optimism And Strong Revenue Growth? - simplywall.st
Medtronic plc tariff impact clarified, shares stay anchored in S&P 500 context - Ad-hoc-news.de
Price to book forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic plc (MDT) CEO Discloses the Impacts of Tariffs on the Company - Insider Monkey
Medtronic adjusts to mixed analyst signals, shares hold steady on NYSE - Ad-hoc-news.de
Enterprise value to EBIT forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic Plc Actuals & Estimates (NYSE:MDT) - TradingView
MDT News | MEDTRONIC PLC (NYSE:MDT) - ChartMill
Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:MDTC34) - TradingView
Medtronic PLC stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Medtronic (NYSE: MDT) EVP Kweli details shares, options and PSU holdings - Stock Titan
Why Did Medtronic Stock Fall Despite Beating Q3 Earnings - Kavout | AI
Enterprise value to revenue forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic reports strongest revenue growth in a decade, shares hold near S&P 500 peer levels - Ad-hoc-news.de
Meyer Handelman Co. Cuts Stock Position in Medtronic PLC $MDT - MarketBeat
Price to earnings forward of Medtronic Plc – LSX:A14M2J - TradingView
Enterprise value to revenue forward of Medtronic Plc – LSX:A14M2J - TradingView
Enterprise value to EBITDA forward of Medtronic Plc – LSX:A14M2J - TradingView
Medtronic raises guidance and shares trade higher on NYSE - Ad-hoc-news.de
Medtronic Plc Actuals & Estimates (BMV:MDT/N) - TradingView
Medtronic Plc Actuals & Estimates (MUN:2M6) - TradingView
Needham Remains Bullish On Medtronic (MDT) Amid Renal Device Growth - Insider Monkey
Medtronic | MDT Stock Price, Company Overview & News - Forbes
Medtronic PLC stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Medtronic reports strongest revenue growth in a decade, shares consolidate on NYSE - Ad-hoc-news.de
Medtronic appoints veteran J&J exec as first CFO of innovation - MedTech Dive
This Undervalued Medical-Devices Stock Is Poised for a Rebound - Barron's
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views? - Yahoo Finance
Medtronic plc (MDT) Stock Analysis: Exploring a 23.52% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews
Medtronic (MDT) Completes $550M Acquisition of Scientia Vascular - Yahoo Finance
Medtronic (MDT) Stock Could Be 12.2% Undervalued After Strong Revenue Growth - simplywall.st
United States Pacemakers Market to Reach US$ 6.99 Billion by 2033 - openPR.com
Medtronic Introduces PulseSelect™ PFA Technology to address India’s Growing AFib and Stroke Burden - Passionate In Marketing
Medtronic completes acquisition of Scientia Vascular - Today's Medical Developments
Medtronic plc 2026 10-K Report: Financial Performance, Business Segments, and Global Operations Overview - Minichart
American Society of Anesthesiologists Announces 12-Year Collaboration with Medtronic as a Corporate Supporter | Newswise - Newswise
[IRANNOTICE] Medtronic plc SEC Filing - Stock Titan
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):